jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

July. 17, 2026

July. 31, 2026

jRCT1050260111

Long-term follow-up of human (allogeneic) iPS cell-derived cardiomyocyte sheet transplantation.

Long-term follow-up of human (allogeneic) iPS cell-derived cardiomyocyte sheet transplantation.

Miyagawa Shigeru

The University of Osaka Hospital

2-15,Yamadaoka,Suita

+81-6-6879-3154

saisentan@tissue.med.osaka-u.ac.jp

Kawamura Takuji

The University of Osaka Hospital

2-15,Yamadaoka,Suita

+81-6-6879-3154

saisentan@tissue.med.osaka-u.ac.jp

Recruiting

July. 17, 2026

10

Observational

single arm study

open(masking not used)

uncontrolled control

single assignment

treatment purpose

Patients enrolled in either of the following studies who have received transplantation of this product
-Clinical trial of human (allogeneic) iPS cell-derived cardiomyocytes sheet for dilated ischemic cardiomyopathy
-Clinical trial of human (allogeneic) iPS cell-derived cardiomyocytes sheet for dilated cardiomyopathy

none

No limit
No limit

Both

Heart disease

ischemic cardiomyopathy,dilated cardiomyopathy

D006331

Survival time

1) Number and rate of clinical events of cardiac function such as death and hospitalization
2) Number and rate of tumor development events
3) Changes and progression of cardiac function
4) Changes and progression of exercise tolerance
5) Changes and progression of laboratory values

None
Instisutional review board of Osaka university hospital
2-2, Yamadaoka, Suita, Osaka

+81-6-6210-8296

rinri@hp-crc.med.osaka-u.ac.jp
Approval

June. 10, 2026

Yes

The deidentified individual subject data will be used for conference presentations, research article,or both. If it is provided to the sponsor, it will be shared based on the contract.

none

History of Changes

No Publication date
2 July. 31, 2026 (this page) Changes
1 July. 17, 2026 Detail